FantasticSearch

1. The Commission shall, by 12 January 2035, carry out an evaluation of this Directive. The evaluation shall be based, inter alia, on the following elements:

(a) the experience gained through the implementation of this Directive;

(b) the data sets from Member States set up in accordance with Article 18(1) and the Union-wide overviews compiled by the EEA in accordance with Article 18(3);

(c) relevant scientific, analytical and epidemiological data;

(d) WHO recommendations, where available.

2. In the context of the evaluation, the Commission shall pay particular attention to the following aspects:

(a) the risk-based approach set out in Article 7;

(b) provisions related to access to water intended for human consumption, set out in Article 16;

(c) provisions concerning the information to be provided to the public under Article 17 and Annex IV.

3. The Commission shall, no later than 12 January 2029, and thereafter where appropriate, submit a report to the European Parliament and to the Council on the potential threat to sources of water intended for human consumption from microplastics, pharmaceuticals and, if necessary, other contaminants of emerging concern, and on the relevant associated potential health risks.